Obstetrics & Gynecology Doctors in Montrose, PA Accepting Medicare

1 Obstetrics & Gynecology doctors found. Showing 1 - 1

Dr. Louis V Gabaldoni, MD Obstetrics & Gynecology Medicare: Accepting Medicare Assignments Practice Location: 100 Hospital Dr, Montrose, PA 18801 Phone: 570-278-3801    Fax: 570-278-4312

News Archive

Study finds different activity patterns of genes in brain of individuals with different genetic backgrounds

Researchers at the Allen Institute for Brain Science have found that the same genes have different activity patterns in the brain in individuals with different genetic backgrounds. These findings may help to explain individual differences in the effectiveness and side-effect profiles of therapeutic drugs and thus have implications for personalized medicine. The study is available in this week's online early edition of the Proceedings of the National Academy of Sciences (www.pnas.org).

Researchers show how attention enhances visual perception

The researchers, from NYU's Department of Psychology and Center for Neural Science, found that attending to, or selectively processing information from a given location without directing our eyes to that location, enhances performance in visual tasks as well as the neural activity underlying the processing of ensuing images. The results are published in the latest issue of the journal Neuron.

The Children's Hospital of Philadelphia establishes Jeffrey Modell Endowed Chair in Pediatric Immunology Research

The Children's Hospital of Philadelphia today announced the establishment of the Jeffrey Modell Endowed Chair in Pediatric Immunology Research.

Malaria parasites alter chemical odor signal of hosts to attract mosquitos

Malaria parasites alter the chemical odor signal of their hosts to attract mosquitos and better spread their offspring, according to researchers, who believe this scent change could be used as a diagnostic tool.

Genervon completes GM604 Phase 2a clinical trial for amyotrophic lateral sclerosis

Genervon Biopharmaceuticals LLC today announced that it has successfully completed its Phase 2a clinical trial for amyotrophic lateral sclerosis ("ALS") disease modification. A full analysis of the trial's results is expected to be completed in the third quarter of 2014, but preliminary data suggests that Genervon's novel, proprietary, multi-target biological drug candidate, GM604, shows significant promise for treating ALS.

Read more Medical News

› Verified 3 days ago